BASSI, NICOLA
 Distribuzione geografica
Continente #
NA - Nord America 4.834
AS - Asia 2.131
EU - Europa 1.199
AF - Africa 440
SA - Sud America 388
OC - Oceania 46
Continente sconosciuto - Info sul continente non disponibili 23
Totale 9.061
Nazione #
US - Stati Uniti d'America 4.612
SG - Singapore 882
CN - Cina 472
HK - Hong Kong 252
BR - Brasile 244
DE - Germania 193
FI - Finlandia 135
IT - Italia 120
VN - Vietnam 98
PL - Polonia 74
GB - Regno Unito 72
SE - Svezia 72
UA - Ucraina 62
RU - Federazione Russa 59
FR - Francia 51
NL - Olanda 46
AR - Argentina 32
TR - Turchia 32
MX - Messico 27
ID - Indonesia 24
JP - Giappone 23
IQ - Iraq 20
NP - Nepal 20
CA - Canada 19
CM - Camerun 19
LY - Libia 19
ZA - Sudafrica 19
AT - Austria 18
KE - Kenya 18
PK - Pakistan 18
RS - Serbia 18
AZ - Azerbaigian 17
PE - Perù 17
DJ - Gibuti 16
EC - Ecuador 16
ES - Italia 16
NZ - Nuova Zelanda 16
PS - Palestinian Territory 16
YE - Yemen 16
BF - Burkina Faso 15
NI - Nicaragua 15
UZ - Uzbekistan 15
CH - Svizzera 14
CL - Cile 14
CZ - Repubblica Ceca 14
DO - Repubblica Dominicana 14
IN - India 14
MA - Marocco 14
PY - Paraguay 14
RW - Ruanda 14
BA - Bosnia-Erzegovina 13
EG - Egitto 13
GT - Guatemala 13
IS - Islanda 13
KH - Cambogia 13
LB - Libano 13
LC - Santa Lucia 13
TN - Tunisia 13
TZ - Tanzania 13
YT - Mayotte 13
BJ - Benin 12
CO - Colombia 12
CU - Cuba 12
DK - Danimarca 12
DZ - Algeria 12
GR - Grecia 12
JO - Giordania 12
MN - Mongolia 12
MU - Mauritius 12
NE - Niger 12
NG - Nigeria 12
NO - Norvegia 12
SK - Slovacchia (Repubblica Slovacca) 12
VE - Venezuela 12
AL - Albania 11
BG - Bulgaria 11
BY - Bielorussia 11
CW - ???statistics.table.value.countryCode.CW??? 11
ET - Etiopia 11
GA - Gabon 11
GH - Ghana 11
IE - Irlanda 11
JM - Giamaica 11
KR - Corea 11
LV - Lettonia 11
MD - Moldavia 11
MY - Malesia 11
PA - Panama 11
PT - Portogallo 11
AE - Emirati Arabi Uniti 10
AM - Armenia 10
AO - Angola 10
BO - Bolivia 10
GN - Guinea 10
HN - Honduras 10
HU - Ungheria 10
IL - Israele 10
KG - Kirghizistan 10
LU - Lussemburgo 10
MG - Madagascar 10
Totale 8.630
Città #
Fairfield 578
Woodbridge 484
Singapore 446
Ashburn 378
Chandler 344
Ann Arbor 332
Houston 270
Jacksonville 255
Hong Kong 246
Seattle 231
Cambridge 225
Wilmington 223
Beijing 127
Boardman 106
Princeton 97
Santa Clara 68
Bytom 62
Medford 61
Nanjing 61
San Jose 57
Des Moines 54
San Diego 44
Helsinki 42
Roxbury 42
Los Angeles 37
Munich 36
Ho Chi Minh City 33
Nanchang 23
New York 22
Dearborn 21
São Paulo 20
Hanoi 18
Baku 16
Shenyang 16
Tripoli 16
Djibouti 15
Padova 15
Kigali 14
Managua 14
Nairobi 14
Tashkent 14
Tokyo 14
Castries 13
Guangzhou 13
Hebei 13
Hefei 13
Jiaxing 13
Amman 12
Buffalo 12
Chicago 12
Cotonou 12
Dar es Salaam 12
Lima 12
Phnom Penh 12
Ulan Bator 12
Boston 11
Havana 11
Jinan 11
Niamey 11
Panama City 11
Redwood City 11
Sanaa 11
Accra 10
Antananarivo 10
Belgrade 10
Bishkek 10
Dakar 10
Harare 10
Johannesburg 10
Norwalk 10
Nuremberg 10
Phoenix 10
Reykjavik 10
Rio de Janeiro 10
Stockholm 10
Vienna 10
Cairo 9
Changsha 9
Conakry 9
Guatemala City 9
Kingstown 9
Libreville 9
Luanda 9
Mamoudzou 9
Milan 9
Noumea 9
Ouagadougou 9
Riga 9
The Dalles 9
Yaoundé 9
Auckland 8
Dallas 8
Dong Ket 8
Dublin 8
Lagos 8
Lahore 8
Lusaka 8
Minsk 8
Rome 8
Willemstad 8
Totale 5.775
Nome #
Anti-SAE antibodies in autoimmune myositis: Identification by unlabelled protein immunoprecipitation in an Italian patient cohort. 241
Anti-dsDNA antibody isotypes in systemic lupus erythematosus: IgA in addition to IgG anti-dsDNA help to identify glomerulonephritis and active disease. 237
In vivo delivery of naked antisense oligos in aged mdx mice analysis of dystrophin restoration in skeletal and cardiac muscle 223
Neurolupus is associated with anti-ribosomal P protein antibodies: an inception cohort study 222
PTX3, Anti-PTX3, and Anti-C1q Autoantibodies in Lupus Glomerulonephritis. 215
17-β-estradiol affects BLyS serum levels and the nephritogenic autoantibody network accelerating glomerulonephritis in NZB/WF1 mice. 213
Autoinflammation and autoimmunity: Bridging the divide. 208
Antigen preparation for immunological studies in systemic autoimmune diseases. 200
Antigen preparation for immunological studies in systemic autoimmune diseases 189
The olfactory function is impaired in patients with idiopathic inflammatory myopathies. 186
Immunization with pentraxin 3 (PTX3) leads to anti-PTX3 antibody production and delayed lupus-like nephritis in NZB/NZW F1 mice. 186
Emerging and critical issues in the pathogenesis of lupus. 170
Serological markers in psoriatic arthritis: promising tools 164
Infections and autoimmunity: the multifaceted relationship. 163
Biological and clinical relevance of anti-prothrombin antibodies. 162
Autoantibodies in polymyositis and dermatomyositis. 162
Diagnostic performance and validation of autoantibody testing in myositis by a commercial line blot assay 160
Commercial blot assays in the diagnosis of systemic rheumatic diseases 159
SLE diagnosis and treatment: When early is early 156
OxLDL/β2GPI-anti-oxLDL/β2GPI complex and atherosclerosis in SLE patients. 153
Autoantibody testing in patients with myositis: clinical accuracy of a multi parametric line immunoassay 147
Infection as triggers and complication of sistemic lupus erythematosus 146
Polymyositis, dermatomyositis and malignancy: a further intriguing link 142
Systemic delivery of therapeutic nucleic acids into skeletal muscle by means of lipid-based vectors 136
Vaccination of mice for research purpose: alum is as effective as and safer than complete Freund adjuvant. 133
Autoantibodies toward pathogenic and protective molecules in systemic lupus erythematosus: anti-oxLDL/ß2GPI and anti-PTX3 antibodies. 133
Serpins, Immunity and Autoimmunity: Old Molecules, New Functions. 129
Anti-PTX3 antibody: a new antibody in lupus. 128
IgG anti-pentraxin 3 antibodies in systemic lupus erythematosus 123
Induction of the 'ASIA' syndrome in NZB/NZWF1 mice after injection of complete Freund's adjuvant (CFA) 122
Galectin-3 in autoimmunity and autoimmune diseases 122
DILAYED SYSTEMIC LUPUS ERYTHEMATOSUS SYMPTOMS AND INCREASED SURVIVAL BY SERPINB3 IN LUPUS-PRONE MICE 121
Studio pilota sull’efficacia di una formulazione micellare contenente un complesso di Au(III) nel trattamento dell’artrite sperimentale da collagene nel topo 121
Disease activity patterns in a monocentric cohort of SLE patients: a seven-year follow-up study. 115
oxLDL/beta 2GPI complex and anti-oxLDL/beta 2GPI in SLE: Prevalence and correlates 113
Anti-MI2 antibody detection in myositis sera by chemiluminescent or chromogenic western blot assay. 111
Autoantibodies, polymorphisms in the serotonin pathway, and human leukocyte antigen class II alleles in chronic fatigue syndrome 110
Aspetti clinici e immunologici associati agli anitcorpi antisintetasi in una casistica di 42 pazienti 108
Pentraxins, anti-pentraxins antibodies and atherosclerosis 108
null 99
Miopatia Subclinica in pazienti affetti da neoplasia del colon-retto: ipotesi sulla patogenesi delle miositi paraneoplastiche 97
NZB/WF1 MICE DEVELOPED ASIA SYNDROME WHEN INJECTED WITH COMPLETE FREUND'S ADJUVANT 94
Expression of regeneration markers in muscle biopsies from patients affected with autoimmune myositis. 92
Subclinical atherosclerosis in patients with psoriatic arthritis. 92
IgG anti-pentraxin 3 antibodies in systemic lupus erythematosus 92
Is C-reactive protein an useful tool in monitoring SLE pregnant women? 91
Predire e valutare la risposta clinica ad abatacept nei pazienti resistenti agli anti-TNF-alfa 91
IgG anti-PTX3 nel lupus eritematoso sistemico 90
Remissione clinica, terapia e danno cumulativo nel lupus eritematoso sistemico: risultati preliminari su una coorte di 100 pazienti 88
The long pentraxin 3 and its role in autoimmunity 86
Multicenter evaluation of a second-generation ELISA assay using the VCP-2 antigen for the detection of anti-citrullinated peptide antibodies 85
The role of IgG, IgM, and IgA anti-DNA isotypes in systemic lupus erythematosus 84
Serological testing in myositis patients: diagnostic accuracy of a commercial line blot assay. 82
Anti-PTX3: are they real? 82
Delay of nephritis in NZB/NZWF1 mice injected with pentraxin 3 81
PENTRAXINA 3 (PTX3) E FIBROSI: STUDIO IMMUNOISTOCHIMICO SU BIOPSIE RENALI IN PAZIENTI CON LES. 79
Diagnosi precoce nel LES. 78
Chronic fatigue syndrome: Characteristics and possible causes for its pathogenesis 76
Il senso dell'olfatto nella poli-dermatomiosite. 76
Livelli sierici di BLyS (B lymphocyte stimulator) in pazienti non selezionati affetti da malattie reumatiche autoimmuni 75
PATHOGENETIC AND PROTECTIVE AUTOANTIBODIES INVOLVED IN LUPUS GLOMERULONEPHRITIS 74
Modulation of glomerunephritis in NZB/WF1 mice: vaccination with PTX3 induces anti-PTX3 antibodies, delays the onset and decreases the severity of glomerulonephritis 73
Antiendothelial and antineuronal cells antibodies in patients with chronic fatigue syndrome. 72
OxLDL/beta2GPI-anti-oxLDL/beta2GPI complex and atherosclerosis in SLE patients. 70
Prevention of glomerulonephritis in NZB/NZWF1 mice by immunization with pentraxin 3. 69
The sense of smell in polimyositis and dermatomyositis. 69
Autoantibody detection in serum of patients with autoimmune myositis: identification of anti-SAE1/SAE2 antibodies by unlabelled protein imunoprecipitation. 67
Relationship between autoantibody profile and muscle histopathological findings in inflammatory myopathies 66
Valutazione dell'accuratezza di un test line blot per la diagnosi sierologica di miosite autoimmune. 65
Reduction of the olfactory function in patients with idiopathic inflammatory myopathies: a case control study. 64
Are anti-P antibodies associated with NPSLE? 63
Prevalence of anti-annexine XI antibodies in patients with autoimmune rheumatic diseases. 59
Immunization of NZB/NZWF1 mice with pentraxin 3 delays the onset and reduces the severity of glomerulonephritis. 59
Diagnostic performance and validation of autoantibody testing in myositis by a commercial line blot assay 57
NZB/WF1 mice developed ASIA syndrome when injected with complete Freund's adjuvant. 57
Modello sperimentale di nefropatia lupica: ruolo della pentraxina 3 56
Immunization with PTX3 induces anti-PTX3 antibodies and delays proteinuria occurence and death in NZB/NZWF1 mice. 49
Effect of SLE pregnancy on serum cytokines. 49
Totale 9.085
Categoria #
all - tutte 26.602
article - articoli 22.111
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 48.713


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021416 0 0 0 0 0 0 27 84 82 90 74 59
2021/2022768 11 107 70 86 21 26 21 93 36 10 67 220
2022/2023686 159 76 7 70 119 89 3 59 67 2 23 12
2023/2024331 17 41 43 27 30 25 28 17 11 6 33 53
2024/20251.393 6 87 73 70 190 23 53 104 117 60 271 339
2025/20262.886 179 479 717 707 473 209 122 0 0 0 0 0
Totale 9.085